- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.23 Exhibit 10.23
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
Exhibit 10.27
AMENDMENT NO. 1 TO
CONTRIBUTION AGREEMENT
This Amendment No.1 to Contribution Agreement (this “Amendment”), effective as of the date of last signature below, hereby amends that certain Contribution Agreement, dated December 31, 2016 (the “Agreement”), betweenSavsu Technologies, LLC, (“Savsu”),biologistix CCM, LLC, (“JV”) andBioLife Solutions, Inc. (“Company”). Terms not defined herein have the meanings ascribed to them in the Agreement.
The Parties entered into the Agreement pursuant to which certain changes in equity ownership were detailed in Section 1.8. The Parties now desire to amend the Agreement as follows:
1. | Section 1.8 of the Agreement, “BLS Post-Closing Transfer of Equity to Savsu” shall be deleted and replaced with the following: |
BLS Post-Closing Transfer of Equity to Savsu: BLS agrees that effective 12/31/17, BLS’s equity ownership will be reduced to 35% from the initial 45%. BLS 35% equity stake will be subject to dilution from any new capital contributions beginning on January 1, 2017.
This Amendment has been executed by the parties on the dates written below.
biologistex CCM, LLC | BIOLIFE SOLUTIONS, INC. | |||
By: | By: | |||
Name: | Name: | |||
Title: | Title: | |||
Date: | Date: | |||
Savsu Technologies, LLC
By: | ||
Name: | ||
Title: | ||
Date: |